EXACT SCIENCES CORP (EXAS)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 811,085 | 706,785 | 708,655 | 699,264 |
| Cost of sales | 248,632 | 206,238 | 196,070 | 189,848 |
| Gross profit, total | 562,453 | 500,547 | - | - |
| Sales and marketing | 247,118 | 264,310 | 194,653 | 185,270 |
| Research and development | 108,901 | 105,310 | 100,101 | 120,884 |
| General and administrative | 208,582 | 220,686 | 217,201 | 201,856 |
| Impairment of long-lived and indefinite-lived assets | - | 6,251 | - | - |
| Operating expenses, total | 564,601 | 596,557 | - | - |
| Other operating income | - | - | 3,100 | 3,800 |
| Impairment of long-lived assets | - | - | 18,698 | 8,152 |
| Amortization of acquired intangible assets | - | - | 24,435 | 23,311 |
| Total operating expenses | - | - | 751,158 | 729,321 |
| Loss from operations | -2,148 | -96,010 | -39,403 | -26,257 |
| Interest expense | - | - | -9,607 | 111 |
| Interest income (expense), net | 9,835 | 9,978 | - | - |
| Investment income, net | 11,926 | 4,997 | 11,582 | 11,801 |
| Total other income (expense) | 2,091 | -4,981 | 1,975 | 11,912 |
| Net loss before tax | -57 | -100,991 | -37,428 | -14,345 |
| Income tax expense | 1,128 | 224 | 808 | 1,463 |
| Net loss | -1,185 | -101,215 | -38,236 | -15,808 |
| Increase (decrease) in net loss per share (in usd per share) | -0.01 | -0.54 | -0.21 | -0.09 |
| Net loss per sharebasic (in usd per share) | -0.01 | -0.54 | -0.21 | -0.09 |
| Weighted average common shares outstandingbasic (in shares) | 188,902,000 | 186,813,000 | 184,795,000 | 184,313,000 |
| Weighted average common shares outstandingdiluted (in shares) | 188,902,000 | 186,813,000 | 184,795,000 | 184,313,000 |